Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

Purpose Artesunate (ART) has been used for a long time in the treatment of Plasmodium falciparum malaria and has been considered safe. The present phase I study aimed to determine the daily dose of ART that is well tolerated as add-on therapy in patients with breast cancer for 4 weeks of therapy. Ot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: König, Miriam (VerfasserIn) , Hagens, Cornelia von (VerfasserIn) , Hoth, Sebastian (VerfasserIn) , Baumann, Ingo (VerfasserIn) , Walter-Sack, Ingeborg (VerfasserIn) , Sertel, Serkan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 January 2016
In: Cancer chemotherapy and pharmacology
Year: 2016, Jahrgang: 77, Heft: 2, Pages: 413-427
ISSN:1432-0843
DOI:10.1007/s00280-016-2960-7
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00280-016-2960-7
Volltext
Verfasserangaben:Miriam König, Cornelia von Hagens, Sebastian Hoth, Ingo Baumann, Ingeborg Walter-Sack, Lutz Edler, Serkan Sertel

MARC

LEADER 00000caa a2200000 c 4500
001 1671375653
003 DE-627
005 20230428190824.0
007 cr uuu---uuuuu
008 190814s2016 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00280-016-2960-7  |2 doi 
035 |a (DE-627)1671375653 
035 |a (DE-599)KXP1671375653 
035 |a (OCoLC)1341235720 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a König, Miriam  |e VerfasserIn  |0 (DE-588)1151358096  |0 (DE-627)1011603020  |0 (DE-576)497705796  |4 aut 
245 1 0 |a Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer  |b new audiological results from a prospective, open, uncontrolled, monocentric phase I study  |c Miriam König, Cornelia von Hagens, Sebastian Hoth, Ingo Baumann, Ingeborg Walter-Sack, Lutz Edler, Serkan Sertel 
264 1 |c 21 January 2016 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.08.2019 
520 |a Purpose Artesunate (ART) has been used for a long time in the treatment of Plasmodium falciparum malaria and has been considered safe. The present phase I study aimed to determine the daily dose of ART that is well tolerated as add-on therapy in patients with breast cancer for 4 weeks of therapy. Ototoxicity could be a potential safety concern in settings different from malaria. Therefore, comprehensive audiological assessment was essential.MethodsThe ARTIC M33/2 study was a prospective, open, uncontrolled, monocentric phase I dose-escalation study to evaluate the safety and tolerability of ART in patients with advanced breast cancer. Patients received either 100, 150 or 200 mg oral ART daily for a test phase of 4 weeks as add-on therapy to their ongoing oncological treatment. For the investigation of the safety of ART for hearing, an audiological assessment was performed with each patient before the intake of ART and after 4 weeks of therapy.ResultsTwenty-three female patients were included in the study. During the test phase, four patients had adverse events (AEs) of the auditory system possibly related to the intake of ART. However, none of these AEs was classified as severe AE (SAE) and did not require treatment interruption. Four patients had AEs concerning the vestibular system (vertigo) during the test phase, one of which was classified as SAE. However, the SAE was fully reversible after discontinuation of ART.ConclusionNone of the audiological results after 4 weeks of therapy with ART showed any dose-limiting auditory toxicity. However, audiological monitoring in further clinical studies with prolonged use of oral ART in doses up to 200 mg daily is warranted.The ARTIC M33/2 study is registered at eudract.ema.europa.eu with the Number 2007-004432-23 and at clinicaltrials.gov with the Number NCT00764036. 
650 4 |a Artesunate 
650 4 |a Breast cancer 
650 4 |a Metastasis 
650 4 |a Ototoxicity 
700 1 |a Hagens, Cornelia von  |e VerfasserIn  |0 (DE-588)1069452521  |0 (DE-627)821926632  |0 (DE-576)429165358  |4 aut 
700 1 |a Hoth, Sebastian  |d 1954-  |e VerfasserIn  |0 (DE-588)115541837  |0 (DE-627)077317998  |0 (DE-576)161494110  |4 aut 
700 1 |a Baumann, Ingo  |d 1977-  |e VerfasserIn  |0 (DE-588)13336982X  |0 (DE-627)544029445  |0 (DE-576)275438732  |4 aut 
700 1 |a Walter-Sack, Ingeborg  |e VerfasserIn  |0 (DE-588)1065347987  |0 (DE-627)815887957  |0 (DE-576)425021408  |4 aut 
700 1 |a Sertel, Serkan  |d 1974-  |e VerfasserIn  |0 (DE-588)173510221  |0 (DE-627)698422635  |0 (DE-576)134355059  |4 aut 
773 0 8 |i Enthalten in  |t Cancer chemotherapy and pharmacology  |d Berlin : Springer, 1978  |g 77(2016), 2, Seite 413-427  |h Online-Ressource  |w (DE-627)253390435  |w (DE-600)1458488-8  |w (DE-576)072283467  |x 1432-0843  |7 nnas  |a Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer new audiological results from a prospective, open, uncontrolled, monocentric phase I study 
773 1 8 |g volume:77  |g year:2016  |g number:2  |g pages:413-427  |g extent:15  |a Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer new audiological results from a prospective, open, uncontrolled, monocentric phase I study 
787 0 8 |i Errata  |a König, Miriam  |t Erratum to  |d 2016  |w (DE-627)1671399226 
856 4 0 |u https://doi.org/10.1007/s00280-016-2960-7  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190814 
993 |a Article 
994 |a 2016 
998 |g 173510221  |a Sertel, Serkan  |m 173510221:Sertel, Serkan  |d 910000  |d 911000  |e 910000PS173510221  |e 911000PS173510221  |k 0/910000/  |k 1/910000/911000/  |p 7  |y j 
998 |g 1065347987  |a Walter-Sack, Ingeborg  |m 1065347987:Walter-Sack, Ingeborg  |d 910000  |d 910100  |e 910000PW1065347987  |e 910100PW1065347987  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 13336982X  |a Baumann, Ingo  |m 13336982X:Baumann, Ingo  |d 910000  |d 911000  |d 50000  |e 910000PB13336982X  |e 911000PB13336982X  |e 50000PB13336982X  |k 0/910000/  |k 1/910000/911000/  |k 0/50000/  |p 4 
998 |g 115541837  |a Hoth, Sebastian  |m 115541837:Hoth, Sebastian  |d 910000  |d 911000  |e 910000PH115541837  |e 911000PH115541837  |k 0/910000/  |k 1/910000/911000/  |p 3 
998 |g 1069452521  |a Hagens, Cornelia von  |m 1069452521:Hagens, Cornelia von  |d 910000  |d 910400  |e 910000PH1069452521  |e 910400PH1069452521  |k 0/910000/  |k 1/910000/910400/  |p 2 
998 |g 1151358096  |a König, Miriam  |m 1151358096:König, Miriam  |d 910000  |d 911000  |e 910000PK1151358096  |e 911000PK1151358096  |k 0/910000/  |k 1/910000/911000/  |p 1  |x j 
999 |a KXP-PPN1671375653  |e 3506955039 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 14.08.2019"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"21 January 2016"}],"title":[{"title":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer","subtitle":"new audiological results from a prospective, open, uncontrolled, monocentric phase I study","title_sort":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer"}],"person":[{"role":"aut","given":"Miriam","family":"König","display":"König, Miriam"},{"role":"aut","given":"Cornelia von","family":"Hagens","display":"Hagens, Cornelia von"},{"display":"Hoth, Sebastian","family":"Hoth","given":"Sebastian","role":"aut"},{"role":"aut","given":"Ingo","family":"Baumann","display":"Baumann, Ingo"},{"family":"Walter-Sack","display":"Walter-Sack, Ingeborg","given":"Ingeborg","role":"aut"},{"role":"aut","given":"Serkan","family":"Sertel","display":"Sertel, Serkan"}],"relHost":[{"language":["eng"],"part":{"year":"2016","text":"77(2016), 2, Seite 413-427","pages":"413-427","extent":"15","volume":"77","issue":"2"},"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 38.1996: Supplement"],"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisher":"Springer"}],"titleAlt":[{"title":"CCP"}],"title":[{"title":"Cancer chemotherapy and pharmacology","title_sort":"Cancer chemotherapy and pharmacology","subtitle":"CCP"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer new audiological results from a prospective, open, uncontrolled, monocentric phase I studyCancer chemotherapy and pharmacology","id":{"zdb":["1458488-8"],"issn":["1432-0843"],"eki":["253390435"]},"recId":"253390435","pubHistory":["1.1978 -"],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1671375653"],"doi":["10.1007/s00280-016-2960-7"]},"recId":"1671375653","name":{"displayForm":["Miriam König, Cornelia von Hagens, Sebastian Hoth, Ingo Baumann, Ingeborg Walter-Sack, Lutz Edler, Serkan Sertel"]},"physDesc":[{"extent":"15 S."}]} 
SRT |a KOENIGMIRIINVESTIGAT2120